首页> 外国专利> METHOD FOR ENHANCING THE IMMUNOTHERAPEUTIC ACTIVITY OF LYMPHOCYTES TO DECREASE THE TUMOR BURDEN BY STIMULATION OF LYMPHOCYTES IN VITRO IN THE PRESENCE OF ANTI-CD3-ANTIBODY AND BY CO-ADMINISTRATION OF IL-2, KITS CONTAINING SUCH ENHANCED LYMPHOCYTES AND THEIR USE IN PREPARATION OF A MEDICAMENT FOR CANCER THERAPY

METHOD FOR ENHANCING THE IMMUNOTHERAPEUTIC ACTIVITY OF LYMPHOCYTES TO DECREASE THE TUMOR BURDEN BY STIMULATION OF LYMPHOCYTES IN VITRO IN THE PRESENCE OF ANTI-CD3-ANTIBODY AND BY CO-ADMINISTRATION OF IL-2, KITS CONTAINING SUCH ENHANCED LYMPHOCYTES AND THEIR USE IN PREPARATION OF A MEDICAMENT FOR CANCER THERAPY

机译:通过在体外存在抗CD3抗体的情况下刺激淋巴细胞和通过共同管理IL-2来增强淋巴细胞减少肿瘤负荷的方法,以降低淋巴瘤的发生率癌症治疗药物

摘要

The present invention is directed to a method of increasing the in vivo immune response of lymphocytes by stimulating the lymphocytes in vitro in the presence of an anti-CD3 monoclonal antibody for less than about 24 hours to form stimulated lymphocytes; infusing the stimulated lymphocytes into a tumor-bearing mammal; and administering IL-2 to the mammal. As a result of this method, the anti-CD3 stimulated lymphocytes display enhanced immunotherapeutic, e.g., cytotoxicity or lymphokine production, in vivo as represented by a decrease in the number of tumors by at least about 20%.
机译:本发明涉及通过在抗CD3单克隆抗体的存在下在体外刺激淋巴细胞少于约24小时以形成刺激的淋巴细胞来增加淋巴细胞的体内免疫应答的方法。将经刺激的淋巴细胞注入患有肿瘤的哺乳动物中;并向哺乳动物施用IL-2。这种方法的结果是,抗CD3刺激的淋巴细胞在体内表现出增强的免疫治疗作用,例如细胞毒性或淋巴因子产生,以肿瘤数目减少至少约20%为代表。

著录项

  • 公开/公告号IL102460A

    专利类型

  • 公开/公告日2001-08-26

    原文格式PDF

  • 申请/专利号IL19920102460

  • 发明设计人

    申请日1992-07-10

  • 分类号A61K35/14;A61K38/20;C12N5/00;A61P35/00;

  • 国家 IL

  • 入库时间 2022-08-22 01:25:08

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号